Rheumatology and Wellness Care

Clinical Research

A Medical Professional analyzing an X-Ray for Clinical Research Purposes.

Willow Rheumatology and Wellness is excited to be at the forefront of bringing new treatments and strategies to improve care through our clinical research department.  We have extensive experience in clinical trials for diseases including rheumatoid arthritis, psoriatic arthritis, polymyalgia rheumatica, giant cell arteritis, and gout.

Frequently Asked Questions

  • We offer a variety of clinical trials for various rheumatologic conditions, including rheumatoid arthritis, psoriatic arthritis, lupus, and other autoimmune diseases.

  • Eligibility criteria vary depending on the specific trial. Generally, participants must meet a certain age, medical history, and other requirements. Our research team will carefully evaluate your eligibility before enrolling you in a trial.

  • All clinical trials carry some degree of risk. Our research team will thoroughly explain the potential risks and benefits of each trial before you decide to participate.

  • Most clinical trials cover the costs of study-related medications and procedures. However, it's important to discuss any potential out-of-pocket costs with our research team before enrolling.

  • You can learn more about our current clinical trials by visiting our website or contacting our research team directly. We're happy to answer any questions you may have and help you determine if a trial is right for you.  

Current Trials

·

Current Trials ·

Psoriatic Arthritis patient holding the hand of a Doctor.

Psoriatic Arthritis

  1. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial.
    Read More →

  2. Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight (TOGETHER-PsA)
    Read More →

  3. The Corrona Psoriatic Arthritis and Spondyloarthritis (PsA-SpA)
    Registry →

Rheumatoid Arthritis patients performing yoga in a park.

Rheumatoid Arthritis

  1. A Study of Baricitinib in Participants With Rheumatoid Arthritis (RA-BRANCH)
    Read More →

  2. Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to a DMARD Starting a New bDMARD or tsDMARD Treatment +/​- csDMARD
    Read More →

  3. Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)
    Read More →

  4. An Adaptive Phase 2a/​2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis
    ReadMore →

  5. Corevitas Rheumatology Biorepository
    Read More →

Closeup of a Woman's face.

Lupus

  1. Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus (SELECT-SLE)
    Read More →

  2. Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). (SIRIUS-SLE LTE)
    Read More →

  3. A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) (BE-EARLY)
    Read More →

An old woman reaching over to the back of her other shoulder.

Giant Cell Arteritis - Polymyalgia Rheumatica

Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Intravenous Secukinumab in Patients With GCA or PMR
Read More →

Closeup of a Patients feet, assumed to be affected by Gout.

Gout

A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory Gout
Read More →

An aged couple performing yoga on the park.